Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside.
Jeongmi Lee, Seung Hyeun Lee
原始摘要（英文原文）· Original abstract
The therapeutic paradigms for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) have entered an unprecedented era of precision oncology, a transformative evolution fundamentally driven by the seamless integration of translational science [...].